Literature DB >> 16547342

Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma.

J Garcia-Arumi, M Morral Palau, M Montolio Gil, H Blasco Garrido, L Sararols Ramsay, A Segura García.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16547342      PMCID： PMC1857019          DOI： 10.1136/bjo.2005.084681

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Combined choroidal and retinal ischemia during interferon therapy: indocyanine green angiographic and microperimetric findings.

Authors:  H Hoerauf; U Schmidt-Erfurth; M Asiyo-Vogel; H Laqua
Journal:  Arch Ophthalmol       Date:  2000-04

2.  Interferon-associated retinopathy and cystoid macular edema.

Authors:  R Tokai; T Ikeda; T Miyaura; K Sato
Journal:  Arch Ophthalmol       Date:  2001-07

3.  Interferon-associated combined branch retinal artery and central retinal vein obstruction.

Authors:  Juan E Rubio; Steve Charles
Journal:  Retina       Date:  2003-08       Impact factor: 4.256

Review 4.  Interferon associated retinopathy.

Authors:  S Hayasaka; Y Nagaki; M Matsumoto; S Sato
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

5.  Retinopathy associated with high-dose interferon alfa-2b therapy.

Authors:  C Hejny; P Sternberg; D H Lawson; K Greiner; T M Aaberg
Journal:  Am J Ophthalmol       Date:  2001-06       Impact factor: 5.258

6.  Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy.

Authors:  Yoav Vardizer; Yifat Linhart; Anat Loewenstein; Hanna Garzozi; Nail Mazawi; Anat Kesler
Journal:  J Neuroophthalmol       Date:  2003-12       Impact factor: 3.042

7.  Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C.

Authors:  S Sugano; M Yanagimoto; T Suzuki; M Sato; H Onmura; H Aizawa; H Makino
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

8.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Authors:  J M Kirkwood; M H Strawderman; M S Ernstoff; T J Smith; E C Borden; R H Blum
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

9.  Retinal complications during interferon therapy for chronic hepatitis C.

Authors:  T Kawano; M Shigehira; H Uto; T Nakama; J Kato; K Hayashi; T Maruyama; T Kuribayashi; T Chuman; T Futami; H Tsubouchi
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.